Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: Pooled data from 10 European registries
Identificadores
Identificadores
Data de publicación
2011Título da revista
Annals of the rheumatic diseases
Tipo de contido
Artigo